Search - tctmd.com

Displaying 421 - 440 of 901

Sort: Relevancy | Date

News Conference News ESC 2020

COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020

Michael O'Riordan

September 04, 2020

News Daily News

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

Michael O'Riordan

September 02, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Daily News

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Michael O'Riordan

August 20, 2020

News Daily News

Better Outcomes, Including Mortality, With IVUS-Guided PCI: Medicare Analysis

Michael O'Riordan

August 18, 2020

News Daily News

Missing EXCEL MI Data Published, Prompting New Questions and Promised Answers

Michael O'Riordan

August 07, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

Thrombus Burden Greater in STEMI Patients With COVID-19

Michael O'Riordan

July 20, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

News Conference News EuroPCR 2020

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Michael O'Riordan

June 30, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Daily News

PCI for Left Main CAD: Meta-analysis Finds No Increased Risk of Mortality

Michael O'Riordan

June 12, 2020

News Daily News

Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients

Michael O'Riordan

June 10, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

Michael O'Riordan

June 01, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Michael O'Riordan

May 15, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

Advertisement

COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Better Outcomes, Including Mortality, With IVUS-Guided PCI: Medicare Analysis

Missing EXCEL MI Data Published, Prompting New Questions and Promised Answers

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Thrombus Burden Greater in STEMI Patients With COVID-19

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

PCI for Left Main CAD: Meta-analysis Finds No Increased Risk of Mortality

Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Coronary Calcium-Guided Statin Strategy Cost-effective in African-Americans

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content